Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21309e85965ed12e07046a4e48d3f828 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-18 |
filingDate |
2017-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a85564831670dbb8d92d71932aa9ca5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46542917292e5211f3d35f7c5e59c86a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53d3a399996c1a2e627f073871945308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fef4481b09955843239cdefc8ec7222 |
publicationDate |
2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2635769-C1 |
titleOfInvention |
Drug based on 5-amino-2,3-dihydrophthalazine-1,4-dione as quick-soluble film for transbuccal introduction |
abstract |
FIELD: pharmacology. n SUBSTANCE: drug in the form of easily soluble biocompatible film for transbuccal application includes a therapeutically effective amount of pharmacologically active agent, such as a salt of alkaline or alkaline-earth metal 5-amino-2.3-dihydrophthalazine-1.4-dione as a waterless salt or its monohydrate or dihydrate, or their mixtures, mucoadhesive film forming polymer plasticiser and taste flavour, represented by a mixture of β-cyclodextrin or modified β-cyclodextrin with sorbitol when their mass ratio of 4:1-1:2, the content of the specified mixture in the film is 15-40 wt % of the weight of the entire film. n EFFECT: increased release speed of the pharmacologically active agent when applying the film, increased transparency, uniformity and stability in storage while retaining elasticity and strength. n 16 cl, 5 tbl |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2699808-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2774597-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2774615-C1 |
priorityDate |
2017-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |